J. Evans, L. Donnelly, A. Emslie-Smith, D. Alessi, A. Morris (2005)
Metformin and reduced risk of cancer in diabetic patientsBMJ : British Medical Journal, 330
P. Horák, A. Crawford, D. Vadysirisack, Zachary Nash, M. DeYoung, D. Sgroi, L. Ellisen (2010)
Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesisProceedings of the National Academy of Sciences, 107
A. Schneider, Rania Younis, J. Gutkind (2008)
Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma.Neoplasia, 10 11
Jingxiang Huang, B. Manning (2008)
The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.The Biochemical journal, 412 2
Gaochao Zhou, R. Myers, Ying Li, Yuli Chen, Xiaolan Shen, J. Fenyk-Melody, Margaret Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M. Hirshman, L. Goodyear, D. Moller (2001)
Role of AMP-activated protein kinase in mechanism of metformin action.The Journal of clinical investigation, 108 8
Adem Kalender, A. Selvaraj, S. Kim, P. Gulati, S. Brûlé, B. Viollet, B. Kemp, N. Bardeesy, P. Dennis, J. Schlager, A. Marette, S. Kozma, G. Thomas (2010)
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.Cell metabolism, 11 5
T. Shoshani, A. Faerman, I. Mett, E. Zelin, Tamar Tenne, S. Gorodin, Y. Moshel, Shlomo Elbaz, A. Budanov, A. Chajut, H. Kalinski, I. Kamer, Ada Rozen, O. Mor, E. Keshet, D. Leshkowitz, P. Einat, R. Skaliter, E. Feinstein (2002)
Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801, Involved in ApoptosisMolecular and Cellular Biology, 22
I. Ben-Sahra, Y. Marchand-Brustel, J. Tanti, F. Bost (2010)
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?Molecular Cancer Therapeutics, 9
(2011)
American Association for Cancer cancerres.aacrjournals.org Downloaded from
D. Kukidome, T. Nishikawa, Kazuhiro Sonoda, Koujiro Imoto, Kazuo Fujisawa, M. Yano, H. Motoshima, T. Taguchi, T. Matsumura, E. Araki (2006)
Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells.Diabetes, 55 1
G. Robert, I. Ben-Sahra, A. Puissant, P. Colosetti, N. Belhacéne, P. Gounon, P. Hofman, F. Bost, J. Cassuto, P. Auberger (2009)
Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell DeathPLoS ONE, 4
L. Ellisen, K. Ramsayer, Cory Johannessen, A. Yang, H. Beppu, K. Minda, J. Oliner, F. McKeon, D. Haber (2002)
REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.Molecular cell, 10 5
M. Buzzai, Russell Jones, R. Amaravadi, J. Lum, R. Deberardinis, F. Zhao, B. Viollet, C. Thompson (2007)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.Cancer research, 67 14
REDD1 Mediates Metformin Antiproliferative Effects
D. Bolster, Stephen Crozier, S. Kimball, L. Jefferson (2002)
AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) Signaling*The Journal of Biological Chemistry, 277
M. Zakikhani, R. Dowling, I. Fantus, N. Sonenberg, M. Pollak (2006)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.Cancer research, 66 21
Claire Regazzetti, F. Bost, Y. Marchand-Brustel, J. Tanti, S. Giorgetti-Peraldi (2009)
Insulin Induces REDD1 Expression through Hypoxia-inducible Factor 1 Activation in Adipocytes*The Journal of Biological Chemistry, 285
I. Ben-Sahra, K. Laurent, S. Giuliano, F. Larbret, G. Ponzio, P. Gounon, Y. Marchand-Brustel, S. Giorgetti-Peraldi, M. Cormont, C. Bertolotto, M. Deckert, P. Auberger, J. Tanti, F. Bost (2010)
Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.Cancer research, 70 6
J. Brugarolas, Kui Lei, R. Hurley, B. Manning, J. Reiling, E. Hafen, L. Witters, L. Ellisen, W. Kaelin (2004)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.Genes & development, 18 23
I. Ben-Sahra, K. Laurent, A. Loubat, S. Giorgetti-Peraldi, P. Colosetti, P. Auberger, J. Tanti, Y. Marchand-Brustel, F. Bost (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 levelOncogene, 27
W. Gotlieb, J. Saumet, Marie-Claude Beauchamp, J. Gu, S. Lau, M. Pollak, I. Bruchim (2008)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.Gynecologic oncology, 110 2
M. DeYoung, P. Horák, Avihu Sofer, D. Sgroi, L. Ellisen (2008)
Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling.Genes & development, 22 2
(2011)
Cancer Res Cancer Research
Cancer Research – Unpaywall
Published: Jun 30, 2011
Access the full text.
Sign up today, get DeepDyve free for 14 days.